Assay
Financial-condition grades for SEC filers
Company Report · as of Oct 9, 2026
|
| Medifast Inc.MED · consumer nondurables | |
|---|---|
| Grade |  A/Bon the A/B boundary of 124 graded peers; percentile 22.0, sampling error 3.8 points; lower is stronger |
| Rank | 28 of 124 |
| Profitability | Apercentile 15.8 |
| Solvency | Apercentile 8.8 |
| Growth and financing | Epercentile 84.5 |
| Reliability | 0.87 AUCfailure model, filers with $120M to $591M assets; 95% interval 0.83 to 0.90; 206 events, 2020 to 2025 |
| Peer failure rate | 1.03% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025 |
| Size band | $120M to $591M assetstotal assets $248.0M[1] |
| Standard universe | insiderevenue above $1M and assets above $10M[1-2] |
| Warnings | none activenot computable: fortress balance sheet |
| Inputs computable | 10 of 14 |
| Graded from | filings received through Feb 17, 2026234 days before the rescan; every figure keyed to the SEC receipt date |
| Last close | $11.462026-10-08; market equity $128.1M; iex feed |
| Price used in grade | None |
| Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date. Open this report as it stood on | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Each date opens the report as it stood on that rescan. |
Business, in the company's words. Opening of Item 1 of the 10-K received Feb 17, 2026; the document on sec.gov.
Medifast, Inc. (“Medifast,” the “Company,” “we” or “us”) is the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system. As we enter 2026, the Company is moving from transformation to execution, leveraging its extensive experience in structured weight loss coupled with recent scientific research and enhanced product offerings to address the needs of a broader metabolic health market. Medifast’s approach focuses on addressing the root cause of metabolic dysfunction.
The Fourteen Inputs [top]
Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.
| Input | Percentile, 0 to 100 | Value | Source | Peer median | Percentile | Peers | Period end |
|---|---|---|---|---|---|---|---|
| Profitability, sleeve percentile 15.8 | |||||||
| Gross profitability | 111.0% | [1,3] | 29.8% | 2.1 | 146 | 2025-12-31 | |
| Return on invested capital | not computable | 5.6% | |||||
| one or more required annual facts are missing | |||||||
| Accruals ratio | (9.6%) | [1,4-6] | (5.0%) | 26.3 | 153 | 2025-12-31 | |
| Gross margin stability, five years | 1.1 pts | [2-3,7-14] | 1.9 pts | 19.1 | 116 | 2025-12-31 | |
| Solvency, sleeve percentile 8.8 | |||||||
| Twelve-month failure probability | 0.02% | 0.03% | 16.7 | 7 | 2026-06-30 | ||
| Altman Z double-prime | 10.15 | [1,15-20] | 3.11 | 3.3 | 122 | 2025-12-31 | |
| Net debt to EBITDA | not computable | 2.54x | |||||
| one or more required annual facts are missing | |||||||
| Interest coverage | not computable | 2.51x | |||||
| latest aligned inputs end 2011-12-31; latest annual assets end 2025-12-31 | |||||||
| Current ratio | 4.69x | [15-16] | 1.81x | 6.4 | 157 | 2025-12-31 | |
| Growth and financing, sleeve percentile 84.5 | |||||||
| Revenue growth, three-year compound | (37.7%) | [2,8,10,12] | 0.2% | 98.5 | 133 | 2025-12-31 | |
| Free cash flow growth, three-year compound | (80.9%) | [5,21-27] | 14.9% | 100.0 | 66 | 2025-12-31 | |
| Reinvestment rate | not computable | 10.7% | |||||
| pretax income must exceed the validity floor and imply a 0%-100% tax rate | |||||||
| Asset growth, three years | (7.8%) | [1,6,28-29] | 0.5% | 80.5 | 134 | 2025-12-31 | |
| Net share issuance, one year | 0.5% | [30-31] | 0.05% | 59.2 | 104 | 2026-02-10 | |
Gross profitability. Revenue less cost of goods sold, over total assets.
Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.
Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.
Twelve-month failure probability. CHS model; lower is stronger.
Net debt to EBITDA. Lower is stronger.
Net share issuance, one year. Split-adjusted; lower is stronger.
Sleeves are equal-weighted; within a sleeve each computable input carries equal weight. Composite -0.306; sampling error 3.8 percentile points on 124 peers.
Among 124 Peers [top]
Composite score of every graded peer, smoothed. Vertical rules are the letter band edges at the 20th, 40th, 60th and 80th percentiles. Small dots are the six largest peers by market equity.
| Rank | Company | Percentile | Letter | Warnings |
|---|---|---|---|---|
| 23 | Daily Journal Corp. (DJCO) Daily Journal Corp. (DJCO) A/Bon the A/B boundary; percentile 17.9 Nasdaq · Newspapers: Publishing or Publishing & Printing market equity $884.0M; last close $632.61 Warnings: late filer, fortress balance sheet; 8 of 14 inputs | 17.9 | A/B | late filer, fortress balance sheet |
| 24 | Cintas Corp. (CTAS) Cintas Corp. (CTAS) A/Bon the A/B boundary; percentile 18.7 Nasdaq · Men's & Boys' Furnishgs, Work Clothg, & Allied Garments market equity $79.9B; last close $201.14 No active warnings; 11 of 14 inputs | 18.7 | A/B | |
| 25 | Brown Forman Corp. (BF-A) Brown Forman Corp. (BF-A) A/Bon the A/B boundary; percentile 19.9 NYSE · Beverages last close $27.08 No active warnings; 10 of 14 inputs | 19.9 | A/B | |
| 26 | Brown Forman Corp. (BF-B) Brown Forman Corp. (BF-B) A/Bon the A/B boundary; percentile 19.9 NYSE · Beverages last close $26.54 No active warnings; 10 of 14 inputs | 19.9 | A/B | |
| 27 | Simply Good Foods Co. (SMPL) Simply Good Foods Co. (SMPL) A/Bon the A/B boundary; percentile 21.1 Nasdaq · Food and Kindred Products market equity $894.3M; last close $10.11 No active warnings; 10 of 14 inputs | 21.1 | A/B | |
| 28 | Medifast Inc. (MED) Medifast Inc. (MED) A/Bon the A/B boundary; percentile 22.0 NYSE · Miscellaneous Food Preparations & Kindred Products market equity $127.8M; last close $11.46 No active warnings; 10 of 14 inputs | 22.0 | A/B | |
| 29 | Mattel Inc. (MAT) Mattel Inc. (MAT) A/Bon the A/B boundary; percentile 22.8 Nasdaq · Dolls & Stuffed Toys market equity $4.7B; last close $16.59 No active warnings; 9 of 14 inputs | 22.8 | A/B | |
| 30 | Superior Group OF Companies, Inc. (SGC) Superior Group OF Companies, Inc. (SGC) A/Bon the A/B boundary; percentile 23.6 Nasdaq · Apparel & Other Finishd Prods of Fabrics & Similar Matl market equity $209.2M; last close $13.01 No active warnings; 7 of 14 inputs | 23.6 | A/B | |
| 31 | Turning Point Brands, Inc. (TPB) Turning Point Brands, Inc. (TPB) Bsecond fifth; percentile 24.4 NYSE · Tobacco Products market equity $1.1B; last close $57.09 No active warnings; 9 of 14 inputs | 24.4 | B | |
| 32 | Tapestry, Inc. (TPR) Tapestry, Inc. (TPR) Bsecond fifth; percentile 25.2 NYSE · Leather & Leather Products market equity $23.1B; last close $115.77 No active warnings; 13 of 14 inputs | 25.2 | B | |
| 33 | Mission Produce, Inc. (AVO) Mission Produce, Inc. (AVO) Bsecond fifth; percentile 26.0 Nasdaq · Agricultural Services market equity $1.0B; last close $11.79 No active warnings; 11 of 14 inputs | 26.0 | B |
| Peer policy | Letter | Percentile | Peers |
|---|---|---|---|
| all graded filers, equal sleeves | A | 16.5 | 2204 |
| sector peers, equal sleeves (the grade) | A/B | 22.0 | 124 |
| same exchange, equal sleeves | A | 17.9 | 984 |
| sector peers, equal inputs | B | 34.1 | 124 |
Each letter is one fifth of the 124 graded peers, about 24 companies. A boundary letter (A/B, B/C, C/D, D/E) marks a percentile within one sampling error of a band edge.
What the Price Implies [top]
Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.
| Measure | Value | Peer median | Percentile | Reading |
|---|---|---|---|---|
| Twelve-month price change, skipping the latest month | (11.2%) | (0.2%) | 33 | hotter than 33 of 100 peers |
| Distance from 52-week high | (18.5%) | (24.8%) | 63 | closer to its high than 63 of 100 peers |
| EBIT to enterprise value | not computable | 4.1% | required accounting or market input is missing | |
| Free cash flow yield | 1.0% | 4.8% | 26 | pricier than 74 of 100 peers |
| Book value to price | 1.54 | 0.57 | 86 | pricier than 14 of 100 peers |
| Sales to price | 3.02 | 1.20 | 83 | pricier than 17 of 100 peers |
| Composite equity issuance, five years | (17.9%) | (16.3%) | 40 | more equity-funded than 40 of 100 peers |
| Relative strength against the sector, log excess return | (0.21) | (0.10) | 33 | ahead of 33 of 100 peers |
Inputs: market equity $127.8M; EBIT -$14.2M; free cash flow $1.2M; book equity $196.4M; sales $385.8M; cash $71.9M[32].
Diagnostics [top]
Diagnostics do not feed the grade.
| Piotroski F-score: None of 9, period end 2025-12-31 | ||
|---|---|---|
| Return on assets above zero | (6.6%) | ✗ fail[4,6] |
| Operating cash flow above zero | $6.9M | ✓ pass[5] |
| Return on assets improved | (7.2 pts) | ✗ fail[4,6,28,33] |
| Operating cash flow exceeds net income | $25.5M | ✓ pass[4-5] |
| Long-term leverage fell | n/a[1,6,28] | |
| Current ratio improved | 135.3 pts | ✓ pass[15-16,34-35] |
| No new shares issued | 0.5% | ✗ fail[30-31] |
| Gross margin improved | (2.5 pts) | ✗ fail[2-3,7-8] |
| Asset turnover improved | (58.7 pts) | ✗ fail[2,6,8,28] |
| Cash, filings, liquidity | |
|---|---|
| Cash and equivalents | $71.9M[36] |
| Operating cash flow, four quarters | $8.8M[5,36-40] |
| Months of runway | not finite |
| trailing operating cash flow is nonnegative, so runway is not finite | |
| Late filings, two years | 0 |
| NT 10-K or NT 10-Q | |
| Days since last periodic filing | 67 |
| 10-Q received Aug 3, 2026 | |
| Median daily dollar volume | $1.4M |
| 63 sessions | |
| Days since newest grade input | 234 |
Downloads [top]
|
Sources [top]
Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.
| # | Concept | XBRL tag | Value | Period end | Received | Form | Links |
|---|---|---|---|---|---|---|---|
| 1 | assets | us-gaap:Assets | $248.0M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 2 | revenue | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $385.8M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 3 | gross profit | us-gaap:GrossProfit | $275.2M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 4 | net income | us-gaap:NetIncomeLoss | -$18.7M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 5 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $6.9M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 6 | assets | us-gaap:Assets | $284.2M | 2024-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 7 | gross profit | us-gaap:GrossProfit | $444.6M | 2024-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 8 | revenue | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $602.5M | 2024-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 9 | gross profit | us-gaap:GrossProfit | $775.9M | 2023-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 10 | revenue | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $1.1B | 2023-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 11 | gross profit | us-gaap:GrossProfit | $1.1B | 2022-12-31 | 2025-02-18 | 10-K | filing · viewer · series |
| 12 | revenue | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax | $1.6B | 2022-12-31 | 2023-02-21 | 10-K | filing · viewer · series |
| 13 | gross profit | us-gaap:GrossProfit | $1.1B | 2021-12-31 | 2024-02-20 | 10-K | filing · viewer · series |
| 14 | revenue | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax | $1.5B | 2021-12-31 | 2023-02-21 | 10-K | filing · viewer · series |
| 15 | current assets | us-gaap:AssetsCurrent | $201.7M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 16 | current liabilities | us-gaap:LiabilitiesCurrent | $43.0M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 17 | retained earnings | us-gaap:RetainedEarningsAccumulatedDeficit | $158.3M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 18 | operating income | us-gaap:OperatingIncomeLoss | -$14.2M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 19 | book equity | us-gaap:StockholdersEquity | $198.9M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 20 | liabilities | us-gaap:Liabilities | $49.1M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 21 | capital expenditure | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | $5.6M | 2025-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 22 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $24.5M | 2024-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 23 | capital expenditure | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | $7.5M | 2024-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 24 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $147.7M | 2023-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 25 | capital expenditure | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | $6.5M | 2023-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 26 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $194.6M | 2022-12-31 | 2025-02-18 | 10-K | filing · viewer · series |
| 27 | capital expenditure | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | $16.7M | 2022-12-31 | 2025-02-18 | 10-K | filing · viewer · series |
| 28 | assets | us-gaap:Assets | $309.9M | 2023-12-31 | 2025-02-18 | 10-K | filing · viewer · series |
| 29 | assets | us-gaap:Assets | $316.2M | 2022-12-31 | 2024-02-20 | 10-K | filing · viewer · series |
| 30 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 10,991,273 | 2026-02-10 | 2026-02-17 | 10-K | filing · viewer · series |
| 31 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 10,937,830 | 2025-02-11 | 2025-02-18 | 10-K | filing · viewer · series |
| 32 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 11,180,703 | 2026-07-27 | 2026-08-03 | 10-Q | filing · viewer · series |
| 33 | net income | us-gaap:NetIncomeLoss | $2.1M | 2024-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 34 | current assets | us-gaap:AssetsCurrent | $214.4M | 2024-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 35 | current liabilities | us-gaap:LiabilitiesCurrent | $64.2M | 2024-12-31 | 2026-02-17 | 10-K | filing · viewer · series |
| 36 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $71.9M | 2026-06-30 | 2026-08-03 | 10-Q | filing · viewer · series |
| 37 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $2.0M | 2026-06-30 | 2026-08-03 | 10-Q | filing · viewer · series |
| 38 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $260,000 | 2026-03-31 | 2026-05-04 | 10-Q | filing · viewer · series |
| 39 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $12.1M | 2025-09-30 | 2025-11-03 | 10-Q | filing · viewer · series |
| 40 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | $28,000 | 2025-06-30 | 2026-08-03 | 10-Q | filing · viewer · series |
Limitations [top]
Grade boundary. Percentile 22.0 is 2.0 points from the nearest band edge; sampling error is 3.8 points.
Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.
Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.
Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.
Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.
Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
